In 2017, hepatitis B was included in the Norwegian Childhood Immunisation Programme and the level of vaccination coverage will be reported.
During the period 2007-2016, the hepatitis B vaccine was only offered to infants whose parents come from countries where the disease is common, so the vast majority of Norwegian infants have not been vaccinated. Vaccination was offered to the children of parents from countries with medium to high prevalence of hepatitis B, including all African and Asian countries, Russia, some Eastern European countries and large parts of South America. During this period, the level of coverage could not be calculated due to the inaccessibility of data on the number of children in the target population. The percentage of children in each birth cohort who received at least one dose of the hepatitis B vaccine has been reported; this percentage was around 28-36 per cent.
From and including 2017, hepatitis B was included in the Norwegian Childhood Immunisation Programme, and the level of coverage will be reported. The Norwegian Childhood Immunisation Programme’s level of coverage has been around 94 per cent.
Data source: Norwegian Immunisation Registry SYSVAK
The data source for this indicator is the Norwegian Immunisation Registry SYSVAK
A description follows below.
The Norwegian Immunisation Registry SYSVAK maintains an overview of the vaccination status of the individual and vaccination coverage in Norway.
The Norwegian Childhood Immunisation Programme includes a range of different vaccines which the health authorities recommend should be given to children and adolescents. Basic vaccination is mainly given to infants and young children, and for most vaccines, booster doses are offered to school-age children. The Norwegian Institute of Public Health is responsible for procuring the vaccines for the Norwegian Childhood Immunisation Programme and distributing them to the municipalities. Vaccination takes place at public health clinics and through the school health service and is free of charge. All administered vaccines are registered at individual level in SYSVAK. The Norwegian Childhood Immunisation Programme publishes an annual report that includes coverage statistics, reported cases of diseases for which vaccination is provided, the type of vaccines that have been used.
Data on hepatitis B vaccination coverage among infants will be reported after 2017.
Global indicator definition
WHO’s definition of the indicator
Indicator 22. Availability, as appropriate, if cost-effective and affordable, of vaccines against human papillomavirus, according to national programmes and policies.
Authors and contacts
Text compiled by the Departments of Vaccine Preventable Diseases and Non-Communicable Diseases at the Norwegian Institute of Public Health.